A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration‐resistant prostate cancer
暂无分享,去创建一个
P. Kantoff | J. Supko | L. Harshman | M. Farina | M. Taplin | C. Sweeney | M. Pomerantz | A. Choudhury | K. Zukotynski | K. Gray | Brandon Bernard | A. Pace